Observational studyEpilepsia2025

Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study.

Simona Lattanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.